<DOC>
	<DOCNO>NCT01969630</DOCNO>
	<brief_summary>To determine patient symptomatic femoropopliteal lesion whether percutaneous revascularization paclitaxel-eluting balloon angioplasty ( PEB ) provisional nitinol stent superior respect 12-month incidence restenosis compare treatment systematic paclitaxel-eluting stent ( PES ) angioplasty</brief_summary>
	<brief_title>Paclitaxel-eluting Balloon Angioplasty With Provisional Use Nitinol Stent Versus Systematic Implantation Paclitaxel-eluting Stent Treatment Femoropopliteal de Novo Lesions</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>intermittent claudication critical limb ischemia de novo stenosis â‰¥ 50 % occlusion least 40 mm length locate femoropopliteal artery presence clear healthy segment lesion superficial femoral common femoral artery popliteal tibioperoneal trunk presence least 1 patent tibial vessel distal runoff ( belowtheknee artery consider patent free obstructive lesion determine angiographic stenosis &gt; 70 % ) life expectancy &lt; 1 year contraindication combine antiplatelet therapy know allergy nickel paclitaxel need major amputation ( MA ) time enrolment Failure recanalize intend belowtheknee artery CLI patient risk major amputation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>femoropopliteal lesion</keyword>
</DOC>